Arcus Biosciences COO Jennifer Jarrett receives $11M in 2020
Arcus Biosciences reports 2020 executive compensation
By ExecPay News
Published: April 20, 2021
Arcus Biosciences reported fiscal year 2020 executive compensation information on April 20, 2021.
In 2020, six executives at Arcus Biosciences received on average a compensation package of $5.4M, a 101% increase compared to previous year.
Average pay of disclosed executives at Arcus Biosciences
Jennifer Jarrett, Chief Operating Officer, received $11M in total. 97% of Jarrett's compensation, or $11M, was in option awards. Jarrett also received $75K in non-equity incentive plan, $125K in salary, $90K in stock awards, as well as $28K in other compensation.
William Grossman, Chief Medical Officer, received a compensation package of $6.1M, which increased by 80% compared to previous year. 55% of the compensation package, or $3.4M, was in stock awards.
Terry Rosen, Chief Executive Officer, earned $5.7M in 2020, a 231% increase compared to previous year.
Juan Carlos Jaen, President and Director, received $3.8M in 2020, which increases by 78% compared to 2019.
Robert C. Goeltz, II, Chief Financial Officer, earned $3.8M in 2020.
Carolyn Tang, General Counsel, received $2.2M in 2020.
Related executives
Terry Rosen
Arcus Biosciences
Chief Executive Officer
Jennifer Jarrett
Arcus Biosciences
Chief Operating Officer
William Grossman
Arcus Biosciences
Chief Medical Officer
Robert Goeltz
Arcus Biosciences
Chief Financial Officer
Juan Jaen
Arcus Biosciences
President and Director
Carolyn Tang
Arcus Biosciences
General Counsel
You may also like
Source: SEC filing on April 20, 2021.